e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
New insights into IIPs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging
Mary McElroy (Edinburgh, United Kingdom), Mary Mcelroy, David Bonnel, Emeline Falaux, Gael Picard de Muller, Fabien Pamelard, Claudio Petterino, Stuart Naylor, Stephen Madden, Jonathan Stauber
Source:
International Congress 2015 – New insights into IIPs
Session:
New insights into IIPs
Session type:
Poster Discussion
Number:
4858
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mary McElroy (Edinburgh, United Kingdom), Mary Mcelroy, David Bonnel, Emeline Falaux, Gael Picard de Muller, Fabien Pamelard, Claudio Petterino, Stuart Naylor, Stephen Madden, Jonathan Stauber. Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging. Eur Respir J 2015; 46: Suppl. 59, 4858
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Pathology of ILDs
Pathology of pulmonary hypertension
Related content which might interest you:
Novel biomarkers in bleomycin-induced pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Transient elastography detection of early liver fibrosis in idiopathic pulmonary fibrosis patients
Source: International Congress 2014 – ILDs 2
Year: 2014
IPFdatabase
– A new tool for a correct application of idiopathic pulmonary fibrosis guidelines
Source: International Congress 2014 – ILDs 2
Year: 2014
Shear Wave imaging (SVI): A potential tool for analyzing early fibrotic changes in the subpleural space
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013
Fibulin-1 is a novel biomarker of disease severity in pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Comparison of densitometric and visual scoring in the assessment of severity of idiopathic fibrotic interstitial pneumonias: Preliminary observations
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Role of midkine in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Changes in the small airways in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Imaging of idiopathic pulmonary fibrosis
Source: International Congress 2016 – Russia Session
Year: 2016
Serum IGFBP2 as a marker of idiopathic pulmonary fibrosis
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Comet tail artifact: A transthoracic chest ultrasound sign useful in assessment of interstitial lung diseases
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
IGFBP-2 a new interesting target in IPF
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014
Club cell secretory protein-CC16 is increased in idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Prognostic value of dual-time-point
18
F-FDG PET in fibrotic idiopathic interstitial pneumonia
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept